Kubota Pharmaceutical Holdings Co (TSE:4596) Total Operating Expense: 円509.20 Mil (TTM As of Mar. 2026)


TSE:4596 Kubota Pharmaceutical Holdings Co Ltd TSE:4596
39 GF Score
Price 円74.00
GF Value 円16.30
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Kubota Pharmaceutical Holdings Co Total Operating Expense?

Kubota Pharmaceutical Holdings Co TSE:4596 +7.25% 39 Total Operating Expense is 円509.20 Mil as of Mar. 2026. GuruFocus rates TSE:4596 with a GF Score™ of 39/100 and a GF Value™ of 円16.30 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Kubota Pharmaceutical Holdings Co's Total Operating Expense for the three months ended in Mar. 2026 was 円316.44 Mil. Kubota Pharmaceutical Holdings Co's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was 円509.20 Mil.

Kubota Pharmaceutical Holdings Co Total Operating Expense Related Terms

Kubota Pharmaceutical Holdings Co Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Kubota Pharmaceutical Holdings Co's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kubota Pharmaceutical Holdings Co Total Operating Expense Chart

Kubota Pharmaceutical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,584.71 2,040.45 1,532.12 1,367.52 890.06

Kubota Pharmaceutical Holdings Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 265.46 192.76 0.00 0.00 316.44
TSE:4596
39GF Score
Kubota Pharmaceutical Holdings Co Ltd TSE:4596
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kubota Pharmaceutical Holdings Co Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円509.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of 円509.20 Mil mean?
Kubota Pharmaceutical Holdings Co (TSE:4596) has a Total Operating Expense of 円509.20 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Kubota Pharmaceutical Holdings Co and its competitors.
Is Kubota Pharmaceutical Holdings Co's Total Operating Expense too high?
Kubota Pharmaceutical Holdings Co's current Total Operating Expense is 円509.20 Mil. Overall, Kubota Pharmaceutical Holdings Co has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Kubota Pharmaceutical Holdings Co's Total Operating Expense compare to VRTX and REGN?
Kubota Pharmaceutical Holdings Co's Total Operating Expense of 円509.20 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Kubota Pharmaceutical Holdings Co and its competitors. Kubota Pharmaceutical Holdings Co's current Total Operating Expense is 円509.20 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kubota Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co (TSE:4596) is currently considered Significantly Overvalued. The stock's GF Value™ is 円16.30, compared to a current price of 円74.00 — trading 354% above its estimated fair value. The current Total Operating Expense is 円509.20 Mil. Kubota Pharmaceutical Holdings Co's overall GF Score™ is 39/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Kubota Pharmaceutical Holdings Co (TSE:4596), the current Total Operating Expense is 円509.20 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Kubota Pharmaceutical Holdings Co (TSE:4596) Overvalued in 2026?

Based on GuruFocus' analysis, Kubota Pharmaceutical Holdings Co stock appears to be overvalued. The current stock price of 円74.00 is trading 354% above its estimated GF Value™ of 円16.30. GuruFocus considers Kubota Pharmaceutical Holdings Co to be Significantly Overvalued.

Key valuation signals for TSE:4596:

  • Total Operating Expense: 円509.20 Mil
  • GF Value™: 円16.30 vs. price of 円74.00 (354% above fair value)
  • GF Score™: 39/100 with 1 warning sign

No single metric tells the full story. See the TSE:4596 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Kubota Pharmaceutical Holdings Co Business Description

Address 1-15-37 Minami-Aoyama, Minato-ku, Tokyo, JPN, 107-0062
Kubota Pharmaceutical Holdings Co Ltd is a Japanese company providing portfolio of drugs and devices to preserve and restore millions of people. It identifies and develops therapeutics to treat the opthalmic disorder and operations incidental or related thereto. Its pipeline products include VCM-Emixustat HCI, Lanosterol and Optogenetics.
39GF Score

Get the complete analysis for TSE:4596

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円74.00
Price
円16.30
GF Value